Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Evaluation of BTV100 in Subjects With Dry Eye Disease
Phase 2
Recruiting
- Conditions
- Dry Eye
- Interventions
- Drug: BTV100 Low doseDrug: BTV100 Mid doseDrug: BTV100 High doseDrug: Placebo
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- BioTheraVision, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT06543303
- Locations
- 🇦🇺
Cataract and Eye Surgery Centre, Victoria, Doncaster East, Victoria, Australia
🇨🇳Taipei Veterans General Hospital, Taipei, Taiwan
🇦🇺Sydney Eye Hospital, Sydney, Australia
News
No news found